Clinical focus Leverage InVivo Therapeutics’ specialized focus on spinal cord injury treatment and their Neuro-Spinal Scaffold to position complementary biomaterials or early-stage device collaborations with neurotrauma clinics, rehab centers, and academic medical centers pursuing SCI therapies.

Regulatory and HUD Target discussions around regulatory pathways and humanitarian use device designation to explore potential partnerships, funding scenarios, or pilot programs with hospitals and insurers seeking innovative yet regulated SCI solutions.

Clinical programs Monitor INSPIRE pivotal study progress and INSPIRE 2.0 data updates to identify collaboration opportunities for trial sites, clinical research organizations, or contract research services that could accelerate patient recruitment and data generation.

Strategic partnerships Capitalize on past partnerships such as the Q Therapeutics collaboration to propose expanded joint development or integration of biomaterial and CNS cell therapy approaches with potential cross-therapy pipelines.

Financial and governance signals Account for recent financial restructurings and leadership appointments to tailor value-driven outreach emphasizing risk-mitigated partnerships, grant-ready projects, and milestone-based collaborations aligned with cash-preservation needs.